Eco Animal Health Group PLC (EAH)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
60.00p
Buy
65.00p
0.00p (+0.00%)
Prices updated at 16 May 2025, 17:15 BST
| Prices minimum 15 mins delay
Prices in GBX
Eco Animal Health Group PLC is a player in the animal health domain. It is a global drug manufacturer, which develops the latest drugs for the treatment of a range of conditions in pets and farm animals.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
-
CEO
Mr. David Charles Hallas
Most recent earnings
31 Mar 2024
Fiscal year end
31 Mar 2024
Employees
227
Head office
100 High street
London
United Kingdom
N14 6BN
Key personnel
Owner name | Salary |
|---|---|
Dr. Frank Murdoch Armstrong Non-Executive Director | - |
Ms. Tracey Dawn James Non-Executive Director | - |
Mr. Christopher John Wilks Executive Director, Chief Financial Officer and Company Secretary | - |
Mr. David Charles Hallas Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Schroder Unit Trusts Limited | 6,500,000 |
| Schroder Instl UK Sm Co Fd | 6,500,000 |
| Schroder Investment Management Limited | 5,200,000 |
| Schroder UK Smaller Companies Fund | 5,200,000 |
| FIL Investment Services (UK) Ltd | 3,809,657 |
Director dealings
Date | Action |
|---|---|
| 25 Apr 2025 | Purchase |
| 02 Dec 2024 | Purchase |
| 15 Oct 2024 | Exercise of Option |
| 30 Aug 2024 | Purchase |
Please note that past performance is not a reliable indicator of future returns.
